Lyme Disease Treatment and Prevention: A Complete Patient's Guide to Current Medical Standards

Table of Contents

• Key Points
• What Is Lyme Disease?
• How This Review Was Conducted
• Who Is at Risk for Lyme Disease?
• The Clinical Picture of Lyme Disease
• How Lyme Disease Is Treated: General Principles
• Erythema Migrans (The Hallmark Rash)
• Borrelial Lymphocytoma
• Lyme Arthritis
• Lyme Carditis
• Acrodermatitis Chronica Atrophicans
• Neuroborreliosis (Nervous System Involvement)
• Prevention: Post-Exposure Prophylaxis
• The Quest for a Vaccine
• What This Means for Patients
• Study Limitations
• Recommendations for Patients
• Frequently Asked Questions
• Source Information

Key Points

• Tick transmission risk increases with attachment time; some Borrelia species can transmit within 24 hours, others after 36 hours.
• Proper tick removal with fine-tipped tweezers prevents regurgitation; avoid squeezing or lubricating the tick.
• Erythema migrans, a bull's-eye rash, appears 3–30 days after a bite and requires prompt antibiotic treatment.
• A single 200 mg doxycycline dose within 72 hours of tick exposure reduces infection risk by up to 87%.
• Most Lyme disease antibiotic courses last 7–28 days; longer treatment has not been shown to improve outcomes.

What Is Lyme Disease?

Lyme borreliosis is a zoonotic disease, meaning it can be transmitted from animals to humans. It is caused by gram-negative Borrelia spirochetes, spiral-shaped bacteria that are carried by certain species of ticks. In European countries, the disease is most often caused by the species Borrelia afzelii or Borrelia garinii, and less frequently by Borrelia burgdorferi. On the North American continent, Borrelia burgdorferi is the most common genospecies responsible for the disease.

The type of tick that transmits the bacteria also varies by region. In Europe, the disease is mainly caused by the bite of Ixodes ricinus and Ixodes persulcatus ticks, while in the United States, Ixodes scapularis and Ixodes pacificus are the primary vectors. The disease is most prevalent in North America, Central and Northern Europe, and Northern Asia.

One of the most important things to understand about Lyme disease is the timing of transmission. When a tick carrying Borrelia afzelii bites, infection can occur in less than 24 hours. For Borrelia burgdorferi carried by Ixodes scapularis ticks, transmission typically occurs after 36 hours of attachment. Interestingly, a large proportion of infections are transmitted by tick nymphs (immature ticks), because they are smaller than mature adults and much more difficult to spot on the skin surface. The risk of transmission increases directly with the length of time an infected tick remains attached to the skin.

The hallmark first sign of infection, called erythema migrans, usually appears at the site of the tick bite within 3 to 30 days. Tick bites occur most often in late spring and early summer, when tick populations surge and people spend more time outdoors. Ticks are commonly found in forests, parks, and meadows, in both urban and suburban areas.

How This Review Was Conducted

The authors of this literature review searched the PubMed database using combinations of key words, including "Lyme disease," "treatment," and "prevention." They focused on the most current evidence, with scientific articles published between 2016 and 2024 accounting for 92% of all references cited in the review.

Inclusion criteria were rigorous. The researchers considered guidelines from European and American societies of epidemiologists, infectious disease physicians, and neurologists, as well as studies from specialized research centers. This included meta-analyses, double-blind randomized trials, and case reports. Studies from inexperienced centers and outdated research that did not follow the latest guidelines were rejected. The goal was to synthesize the opinions of many scientific societies to present the developed standards and consolidate knowledge on Lyme disease prevention.

Who Is at Risk for Lyme Disease?

Several factors increase the risk of contracting Lyme disease, and knowing them can help you take appropriate precautions:

• Occupational exposure: Forest workers and hunters face significantly higher risk due to frequent time spent in tick habitats.
• Recreational and lifestyle factors: Spending time in forests in endemic areas without proper preparation, as well as activities like pilgrimages and gardening, increase exposure.
• Prolonged tick attachment: The longer a tick remains on the skin, the higher the risk of bacterial transmission.
• Improper tick removal: Attempting to squeeze or lubricate ticks is dangerous. This can cause the tick to vomit, which increases the risk of bacteria and viruses entering the human body.

The Clinical Picture of Lyme Disease

Lyme disease can be divided into two main forms: early and late. The early form is further subdivided into localized (limited) and disseminated (spreading) stages. Understanding this progression helps patients recognize symptoms early.

The early localized form is the most common, and its first symptom is usually erythema migrans. This is a gradually enlarging, ring-shaped skin lesion with central clearing and a red border, often described as a "bull's-eye" rash. The lesion appears between 3 and 30 days after a tick bite, most commonly after about 7 days. In addition to the rash, early localized Lyme disease can include flu-like symptoms and, less commonly, a Lyme lymphocytoma, which is a painless nodule that may appear in the earlobe or scrotal region.

The early disseminated stage develops weeks to a few months after infection. Its symptoms include:

• Arthritis (joint inflammation)
• Myocarditis (inflammation of the heart muscle)
• Neuroborreliosis, which can present as lymphocytic meningitis (inflammation of the membranes covering the brain) or cranial neuritis (inflammation of the cranial nerves)

The late form of Lyme disease can include chronic atrophic dermatitis (skin changes), chronic arthritis, and rarely, chronic neuroborreliosis. These late manifestations can appear months to years after the initial infection.

How Lyme Disease Is Treated: General Principles

Treatment of Lyme disease is based on specific antibiotic therapy, and the choice of drug depends on the form of the disease, which organs are involved, and the patient's age. It is important to note that very broad-spectrum antibiotics such as fluoroquinolones or aminoglycosides are not recommended for Lyme disease.

The duration of antibiotic treatment should usually be limited to 28 days. Longer therapy has not been shown to be beneficial and may only increase the risk of side effects. For flu-like symptoms, non-steroidal anti-inflammatory drugs (NSAIDs) are recommended. In cases of large amounts of joint effusion (fluid accumulation in a joint), a puncture may be performed for decompression, which helps reduce pain.

A key trend highlighted in this review is that recent evidence supports shorter courses of antibiotic therapy, showing similar cure rates for patients receiving both long and short treatment. This matters in the context of finding the shortest effective treatment period, reducing antibiotic resistance, and minimizing the adverse effects of prolonged antibiotic exposure.

Erythema Migrans (The Hallmark Rash)

The appearance of erythema migrans after a tick bite undoubtedly requires treatment without expanding the diagnostic workup. Because the rash appears within 30 days after the bite, patients are advised to observe the bite site during this entire period. Different medical societies have issued slightly different but broadly similar guidelines for treating this early manifestation.

According to the National Institute for Health and Clinical Excellence (NICE) from the UK, doxycycline is the treatment of choice for 21 days, at a dose of 200 mg once a day, or in two divided doses of 100 mg each. In contrast, the combined guidelines from the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) indicate doxycycline for 10 days, or amoxicillin 500 mg three times a day for 14 days, or cefuroxime axetil 500 mg twice daily as first-line treatment.

Polish guidelines from the Society of Epidemiologists and Physicians of Infectious Diseases (PTEiLChZ) recommend doxycycline for 7 to 21 days, or amoxicillin or cefuroxime axetil for 14 to 21 days. The shorter doxycycline course reflects a study showing that 7-day antibiotic therapy had comparable cure rates to 2-week therapy, while allowing patients less time exposed to the medication.

Spanish societies, including the Society of Infectious Diseases and Clinical Microbiology (SEIMC), Society of Neurology (SEN), Society of Immunology (SEI), Spanish Society of Paediatric Infectology (SEIP), Society of Rheumatology (SER), and the Academy of Dermatology and Venereology (AEDV), jointly recommend doxycycline first for 10 to 21 days. As a second choice, they recommend amoxicillin or cefuroxime axetil for 14 to 21 days.

If a patient has contraindications to both doxycycline and amoxicillin or cefuroxime, azithromycin 500 mg once a day for 5 to 10 days is recommended as an alternative.

Borrelial Lymphocytoma

Borrelial lymphocytoma is a skin manifestation of Lyme disease that usually presents as a purplish nodule. It most often appears within 2 to 8 weeks after infection and is more frequently seen in children. In adults, it most commonly occurs on the nipple, earlobe, or scrotum, and less frequently in other locations.

When a patient tests positive for specific IgG or IgM antibodies, antibiotic treatment is initiated. The Polish PTEiLChZ guidelines recommend doxycycline, amoxicillin, or cefuroxime axetil for 14 to 21 days. The IDSA/AAN/ACR guidelines recommend using these same antibiotics for 14 days.

Lyme Arthritis

Lyme arthritis is a condition that typically affects the large joints, mainly the knees, shoulders, elbows, and ankles. It appears a few weeks after infection and can last up to several months. Sometimes, despite treatment, it progresses to persistent arthritis. Patients experience periods of exacerbation that become increasingly shorter as the disease progresses, with swelling and pain in the affected joints during flare-ups.

The Polish, Spanish, and US guidelines all recommend doxycycline, amoxicillin, or cefuroxime axetil for 4 weeks at the first episode. The UK NICE guidelines also recommend 4 weeks of therapy, but list doxycycline as the drug of first choice. For recurrent arthritis, intravenous ceftriaxone is recommended for 14 to 28 days, or alternatively, repeating the original antibiotic therapy.

Lyme Carditis

Lyme carditis, or heart involvement in Lyme disease, occurs in approximately 0.5% to 5% of patients. It belongs to the early disseminated stage of the disease and usually develops within 3 weeks, though it can appear even after several months. The main clinical manifestation in patients with Lyme carditis is atrioventricular (AV) blocks, usually of the 1st or 2nd degree.

This condition warrants serious attention: up to 67% of affected patients may subsequently develop complete heart block and require pacemaker support. Less commonly, cardiac involvement can manifest as endocarditis (inflammation of the heart's inner lining), pericarditis (inflammation of the sac around the heart), myocardial infarction (heart attack), atrial and ventricular arrhythmias, dilated cardiomyopathy, or heart failure.

Because of this, experts recommend that Lyme disease be ruled out in young patients before permanent pacemaker placement. After causal treatment with appropriate antibiotic therapy, these patients typically no longer have symptoms of conduction disturbances and do not require pacing.

Treatment recommendations differ slightly by organization. The Polish guidelines recommend antibiotics (doxycycline, amoxicillin, cefuroxime, or intravenous ceftriaxone) for 14 to 21 days. As second-line treatment, intravenous cefotaxime or penicillin G can be used for 14 to 21 days. The NICE guidelines recommend that hemodynamically stable patients (those with normal blood pressure and circulation) with myocarditis be treated with doxycycline for 21 days, while hemodynamically unstable patients should receive intravenous ceftriaxone for 21 days.

Acrodermatitis Chronica Atrophicans

Acrodermatitis chronica atrophicans is among the late manifestations of Lyme disease and can appear from several months to even several years after the initial infection. It initially manifests as bluish-red lesions on the surface of the extremities, accompanied by swelling and pain. If left untreated, it progresses to fibrosis (thickening and scarring of connective tissue) and skin atrophy (thinning and degeneration of the skin). Patients often also experience clinical features of peripheral neuropathy (nerve damage causing numbness, tingling, or pain).

The presence of specific IgG class antibodies, a positive histopathological examination of the altered skin, or the finding of Borrelia genetic material in a skin biopsy are indications for starting treatment. Antibiotic therapy should last 21 to 28 days, with doxycycline, amoxicillin, or cefuroxime as the drugs of choice. UK guidelines specifically recommend doxycycline for 4 weeks as first-line treatment, which can be followed by oral amoxicillin or intravenous ceftriaxone for 28 days.

Neuroborreliosis (Nervous System Involvement)

Neuroborreliosis is a broad term encompassing nervous system involvement in the course of Lyme disease. It occurs in the vast majority of early forms, appearing up to several months after infection. Notably, erythema migrans co-occurs in about 40% of patients with neuroborreliosis.

Typical clinical conditions in early neuroborreliosis include:

• Meningitis (inflammation of the membranes around the brain and spinal cord)
• Cranial nerve palsy (weakness or paralysis of nerves originating from the brain)
• Spinal root involvement (radiculopathy, causing pain, numbness, or weakness along nerve pathways)

Late neuroborreliosis can manifest as inflammation of the brain and spinal cord, with spastic symptoms, mobility disorders, and micturition (urination) disturbances. The most common set of symptoms is known as the Garin-Bujadoux-Bannwarth syndrome, which consists of meningitis, cranial nerve palsy, and root syndrome.

When cranial nerves are involved, all of them — with the exception of the olfactory nerve (responsible for smell) — may be paralyzed. Most often, the facial nerve is paralyzed unilaterally (on one side) and somewhat less often bilaterally (on both sides). The good news: symptoms of paralysis usually resolve within 8 weeks.

Diagnosis requires careful evaluation. When the central nervous system is involved and causes other than Lyme disease have been excluded, the presence of intrathecal synthesis of specific antibodies (antibodies produced within the spinal fluid) is required, and the demonstration of pleocytosis (an increased number of white blood cells in the cerebrospinal fluid) is helpful. For symptoms from the peripheral nervous system, the presence of specific antibodies in the serum (blood) is required after excluding other causes.

For cranial nerve palsy, doxycycline is usually recommended for 14 to 21 days. Meningitis most commonly requires doxycycline or intravenous ceftriaxone for 14 to 21 days. In some cases, penicillin G can be used as second-line treatment.

Prevention: Post-Exposure Prophylaxis

When it comes to preventing Lyme disease after a tick bite, the IDSA, AAN, and ACR guidelines recommend that people who have experienced multiple tick bites outside endemic areas be treated with a single dose of doxycycline 200 mg orally within 72 hours of tick exposure.

The evidence supporting this approach is compelling. An open-label, randomized, controlled trial found that patients who received a single 200 mg dose of doxycycline within 72 hours after removing a tick from their skin had a 67% lower risk of contracting Lyme disease compared to patients who did not take the antibiotic. Even more impressively, a meta-analysis of 4 studies showed that a single dose of doxycycline taken within 72 hours protects against Lyme disease in 87% of cases.

The Quest for a Vaccine

Currently, there are no registered vaccines to protect against contracting Lyme disease. However, research is actively underway. Scientists are studying proteins produced by Borrelia spirochetes that are expected to help in the future development of effective vaccines. The difficulty in developing a good vaccine lies in the complexity of the bacteria and the need to provide protection against multiple genospecies prevalent in different geographic regions. Despite these challenges, vaccine development remains an intensive area of research.

What This Means for Patients

This review of international guidelines offers several important takeaways for patients. First, most cases of Lyme disease can be effectively treated with oral antibiotics, and the duration of treatment is now recognized to be shorter than previously thought — usually no more than 28 days, and often just 7 to 21 days for early localized disease. Second, early recognition of erythema migrans is critical: if you see a bull's-eye rash after a tick bite, seek medical attention without delay.

For those who find an attached tick, proper removal is essential. Do not squeeze or lubricate the tick, as this can cause it to regurgitate bacteria into your bloodstream. Instead, use fine-tipped tweezers to grasp the tick close to the skin and pull upward with steady, even pressure. If you are in a high-risk situation, ask your doctor whether a single dose of doxycycline within 72 hours is appropriate for you.

The review also emphasizes that there is no role for prolonged or repeated antibiotic courses in most cases of Lyme disease. Patients who continue to feel unwell after completing appropriate antibiotic therapy should discuss their symptoms with a healthcare provider rather than seeking additional antibiotics on their own.

Study Limitations

This is a literature review, which means it synthesizes findings from existing studies rather than presenting new primary research. The authors noted that they excluded studies from inexperienced centers and outdated studies that did not follow the latest guidelines, which is a strength in terms of quality control but may also introduce selection bias. Differences between the guidelines of various national societies reflect ongoing uncertainty about optimal treatment durations and drug choices, particularly for less common manifestations such as Lyme carditis and neuroborreliosis.

Additionally, most randomized trial data focuses on early localized disease (erythema migrans), while recommendations for rarer manifestations such as acrodermatitis chronica atrophicans are based on smaller studies and expert opinion. The efficacy of post-exposure prophylaxis is based on a limited number of trials, and the optimal timing and dosing continue to be refined.

Recommendations for Patients

Based on these international guidelines, here is what patients should know and do:

1. Prevent tick bites: When in forests, parks, or meadows — especially in late spring and early summer — wear long sleeves and pants, tuck pants into socks, and use EPA-approved insect repellents. Check your body thoroughly for ticks after outdoor activities.
2. Remove ticks properly: Use fine-tipped tweezers to grasp the tick as close to the skin as possible and pull upward with steady pressure. Avoid squeezing, crushing, or applying lubricants to the tick.
3. Observe the bite site for 30 days: If a rash develops at the site — particularly a ring-shaped, expanding lesion — see a healthcare provider promptly. Erythema migrans requires treatment without further diagnostic delay.
4. Consider post-exposure prophylaxis: If you have had multiple tick bites, ask your healthcare provider about a single 200 mg dose of doxycycline taken within 72 hours of exposure. This can reduce your risk of Lyme disease by up to 87%.
5. Take antibiotics exactly as prescribed: Complete the full course of antibiotics as directed. The recommended duration is typically 7 to 28 days depending on the clinical manifestation and the guideline followed. Longer therapy is usually not beneficial and may cause side effects.
6. Watch for symptoms of disseminated disease: If you develop joint pain, facial weakness, palpitations, irregular heartbeat, or neurological symptoms weeks to months after a tick bite, inform your healthcare provider about the exposure and ask about testing for Lyme disease.
7. Know that a vaccine is not yet available: Stay informed about ongoing research and clinical trials, but for now rely on personal protective measures and prompt treatment.

This means that with appropriate awareness, timely tick removal, and adherence to evidence-based treatment guidelines, the vast majority of Lyme disease cases can be successfully managed.

Frequently Asked Questions

How quickly can Lyme disease be transmitted after a tick bite?

Transmission time depends on the tick and bacteria. In Europe, Borrelia afzelii can infect in under 24 hours. In the US, Borrelia burgdorferi carried by Ixodes scapularis ticks typically transmits after 36 hours of attachment. The risk rises the longer an infected tick stays attached.

What should I do if I find a tick attached to my skin?

Use fine-tipped tweezers to grasp the tick as close to the skin as possible and pull upward with steady, even pressure. Do not squeeze, crush, or apply lubricants, as this can cause the tick to regurgitate bacteria. After removing it, observe the bite site for 30 days and see a doctor if a rash develops.

What does the Lyme disease rash look like and when does it appear?

The hallmark rash, erythema migrans, is a gradually enlarging ring-shaped lesion with central clearing and a red border, often called a bull's-eye rash. It usually appears at the tick bite site within 3 to 30 days, most commonly after about 7 days. If you see it, seek medical attention promptly.

Can a single dose of doxycycline prevent Lyme disease after a tick bite?

Yes. Guidelines recommend a single 200 mg dose of doxycycline taken within 72 hours of tick exposure for people with multiple tick bites. In one randomized trial, this lowered risk by 67%, and a meta-analysis of 4 studies found protection in 87% of cases. Ask your doctor whether it is right for you.

How long is antibiotic treatment for early localized Lyme disease?

Treatment for erythema migrans typically lasts 7 to 21 days, depending on the guideline. Doxycycline is commonly used for 10 to 21 days, or amoxicillin or cefuroxime for 14 to 21 days. Total antibiotic treatment for Lyme disease is usually no longer than 28 days; longer courses have not been shown to help.

What symptoms may appear in later or disseminated Lyme disease?

Weeks to months after infection, late or disseminated Lyme disease can cause joint pain and swelling (arthritis), facial nerve palsy, palpitations or irregular heartbeat (carditis), and neurological symptoms like meningitis or radiculopathy. If you have these symptoms after a tick bite, inform your healthcare provider about the exposure and ask about testing.

Source Information

This patient-friendly article is based on the following peer-reviewed research:

• Original title: Current methods of treatment and prevention of Lyme borreliosis – literature review
• Authors: Grzegorz Pyc, Jan Kowalewski, Aleksandra Dąbrowska, Damian Bęben, Maria Dudzik, Kornel Majewski, Kinga Pakos, Kamila Durmała, Urszula Sielicka, Jakub Mączka
• Journal: Journal of Pre-Clinical and Clinical Research, 2024, Vol 18, No 3, pages 276–281
• DOI: 10.26444/jpccr/192029
• Publication dates: Received June 5, 2024; accepted August 5, 2024; first published September 9, 2024
• Author affiliations: Medical University institutions in Szczecin, Poznań, and Wrocław, Poland, including the Department of Nephrology, Transplantology and Internal Diseases at Pomeranian Medical University, the Clinical Department of Cardiology and Internal Diseases at the University Clinical Hospital in Poznań, and military clinical hospitals in Szczecin and Wrocław.

This patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and should not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment of Lyme disease or any other medical condition.